OBJECTIVE: To extend development of a pediatric inflammatory bowel disease (IBD) health-related quality of life (HRQoL) measure by determining its factor structure and associations of factors with generic HRQoL measures and clinical variables. PATIENTS AND METHODS: Cross-sectional survey of children and adolescents ages 8 years to 18 years and their parents attending any of 6 US IBD centers, recruited from either existing registry of age-eligible subjects or visits to participating centers. The survey included generic (Pediatric Quality of Life Inventory) and IBD-specific (Impact Questionnaire) quality of life measures, disease activity, and other clinical indicators. We carried out factor analysis of Impact responses, comparing resulting factors with results on the generic HRQoL and the clinical measures. RESULTS: We included 220 subjects (161 with Crohn disease and 59 with ulcerative colitis). Initial confirmatory factor analysis did not support the 6 proposed Impact domains. Exploratory factor analysis indicated 4 factors with good to excellent reliability for IBD responses: general well-being and symptoms, emotional functioning, social interactions, and body image. Two items did not load well on any factor. The 4 factors correlated well with the Pediatric Quality of Life Inventory and subscales. Children with higher disease activity scores and other indicators of clinical activity reported lower HRQoL. CONCLUSIONS: This study provides further characteristics of a HRQoL measure specific to pediatric IBD and indicates ways to score the measure based on the resulting factor structure. The measure correlates appropriately with generic HRQoL measures and clinical severity indicators.
OBJECTIVE: To extend development of a pediatric inflammatory bowel disease (IBD) health-related quality of life (HRQoL) measure by determining its factor structure and associations of factors with generic HRQoL measures and clinical variables. PATIENTS AND METHODS: Cross-sectional survey of children and adolescents ages 8 years to 18 years and their parents attending any of 6 US IBD centers, recruited from either existing registry of age-eligible subjects or visits to participating centers. The survey included generic (Pediatric Quality of Life Inventory) and IBD-specific (Impact Questionnaire) quality of life measures, disease activity, and other clinical indicators. We carried out factor analysis of Impact responses, comparing resulting factors with results on the generic HRQoL and the clinical measures. RESULTS: We included 220 subjects (161 with Crohn disease and 59 with ulcerative colitis). Initial confirmatory factor analysis did not support the 6 proposed Impact domains. Exploratory factor analysis indicated 4 factors with good to excellent reliability for IBD responses: general well-being and symptoms, emotional functioning, social interactions, and body image. Two items did not load well on any factor. The 4 factors correlated well with the Pediatric Quality of Life Inventory and subscales. Children with higher disease activity scores and other indicators of clinical activity reported lower HRQoL. CONCLUSIONS: This study provides further characteristics of a HRQoL measure specific to pediatric IBD and indicates ways to score the measure based on the resulting factor structure. The measure correlates appropriately with generic HRQoL measures and clinical severity indicators.
Authors: Anne M Griffiths; Anthony R Otley; Jeffrey Hyams; Antonio R Quiros; Richard J Grand; Athos Bousvaros; Brian G Feagan; George R Ferry Journal: Inflamm Bowel Dis Date: 2005-02 Impact factor: 5.325
Authors: Nader N Youssef; Annette L Langseder; Barbara J Verga; Richard L Mones; Joel R Rosh Journal: J Pediatr Gastroenterol Nutr Date: 2005-07 Impact factor: 2.839
Authors: P G Farup; T A Hinterleitner; M Lukás; X Hébuterne; D Rachmilewitz; M Campieri; R Meier; R Keller; B Rathbone; E Oddsson Journal: Inflamm Bowel Dis Date: 2001-08 Impact factor: 5.325
Authors: James W Varni; Mariella M Lane; Tasha M Burwinkle; Eve N Fontaine; Nader N Youssef; Jeffrey B Schwimmer; Perrie E Pardee; John F Pohl; David J Easley Journal: J Dev Behav Pediatr Date: 2006-12 Impact factor: 2.225
Authors: Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag Journal: J Pediatr Date: 2005-01 Impact factor: 4.406
Authors: Helene Werner; Markus A Landolt; Patrick Buehr; Rebekka Koller; Andreas Nydegger; Johannes Spalinger; Klaas Heyland; Susanne Schibli; Christian P Braegger Journal: Qual Life Res Date: 2017-02-14 Impact factor: 4.147
Authors: Steven Hoffman; Matthew C Lambert; Timothy D Nelson; Alexandra L Trout; Michael H Epstein; Robert Pick Journal: Qual Life Res Date: 2012-11-30 Impact factor: 4.147
Authors: Deepal H Dalal; Dana Patton; Janet M Wojcicki; Ann L Clark; Elizabeth A Garnett; Melvin B Heyman Journal: J Pediatr Gastroenterol Nutr Date: 2012-10 Impact factor: 2.839
Authors: Jamie L Ryan; Michael W Mellon; Katherine W F Junger; Elizabeth A Hente; Lee A Denson; Shehzad A Saeed; Kevin A Hommel Journal: Inflamm Bowel Dis Date: 2013-11 Impact factor: 5.325
Authors: Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel Journal: J Pediatr Gastroenterol Nutr Date: 2013-04 Impact factor: 2.839
Authors: Rona L Levy; Miranda A L van Tilburg; Shelby L Langer; Joan M Romano; Lynn S Walker; Lloyd A Mancl; Tasha B Murphy; Robyn L Claar; Shara I Feld; Dennis L Christie; Bisher Abdullah; Melissa M DuPen; Kimberly S Swanson; Melissa D Baker; Susan A Stoner; William E Whitehead Journal: Inflamm Bowel Dis Date: 2016-09 Impact factor: 5.325